BIOMIN HOLDING GMBH

Their core work

BIOMIN is an Austrian animal nutrition and feed additives company specializing in mycotoxin risk management, gut health solutions, and feed safety for livestock. They develop and test feed strategies — including gut stabilizers, immunostimulants, and bacteriophages — as alternatives to conventional antimicrobials in pig and poultry production. In H2020 projects, they contribute applied industry expertise in feed formulation, mycotoxin reduction technologies, and farm-level trials, bridging the gap between laboratory research and commercial animal nutrition products.

What they specialise in

How they've shifted over time

BIOMIN's early H2020 work (2016–2018) centered on classical feed safety — mycotoxin management and aquafeed improvement. From 2019 onward, their focus shifted markedly toward antimicrobial alternatives, gut microbiome science, and advanced omics-based approaches (hologenomics, metagenomics, systems biology). This trajectory reflects the broader industry pivot from chemical feed additives toward biology-driven, precision animal nutrition.

BIOMIN is moving from traditional feed additive expertise toward microbiome-informed, biology-first solutions for animal health — making them a strong partner for projects targeting antimicrobial resistance or precision livestock nutrition.

How they like to work

BIOMIN consistently joins as a participant or third party rather than leading consortia, positioning themselves as an industry partner that brings commercial feed expertise and access to farm-level trial infrastructure. With 73 unique partners across 20 countries in just 5 projects, they integrate into large, diverse research consortia. This pattern suggests they are sought after as the applied-industry voice that can validate research findings in real production settings.

Despite only 5 projects, BIOMIN has built a remarkably broad network of 73 partners across 20 countries, reflecting their role in large multi-partner consortia. Their reach spans most of the EU, with no narrow geographic clustering.

What sets them apart

BIOMIN occupies a rare position as a large private company that actively participates in academic-led research consortia on animal nutrition and feed safety. Unlike university partners, they bring commercial product development pipelines and access to real farm trials, which means research findings can be validated and scaled faster. For consortium builders, they offer the credibility and infrastructure of a major feed industry player without the bureaucracy of a public institution.

Highlights from their portfolio

• AVANT
  Largest single EC contribution (EUR 123,333) and directly addresses the high-priority EU agenda on reducing antimicrobial use in livestock through practical feed-based alternatives.
• MyToolBox
  Comprehensive mycotoxin management project (EUR 103,441) covering the entire food chain from field to fork, aligning with BIOMIN's core commercial domain.
• 3D-omics
  Represents BIOMIN's most scientifically advanced engagement, applying multi-omics and hologenomics to animal production — signaling their move into data-driven nutrition science.